Rhomboid Intercostal Block vs Erector Spinae Block
Recruiting · NCT07040618 · Interventional (participants receive a specific treatment) · Lead sponsor: Cairo University
View the official record on ClinicalTrials.gov →Interventions studied
Ultrasound-guided Erector Spinae Plane BlockUltrasound-guided Rhomboid Intercostal Block
What this trial is about
This randomized trial compares rhomboid intercostal block (RIB) and erector spinae plane block (ESPB) for postoperative pain control in lung cancer patients undergoing thoracotomy. Sixty patients will be assessed for 24-hour morphine consumption, pain scores, hemodynamics, recovery time, satisfaction, and side effects. The study aims to identify the more effective technique for enhancing recovery and minimizing opioid use.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients undergoing thoracotomy for lung cancer
- Age ≥ 18 years and ≤ 65 years
- ASA physical status II or III
- Body Mass Index (BMI) \> 20 kg/m² and \< 35 kg/m²
- Willing and able to provide informed consent
Exclusion criteria
- Patient refusal
- ASA physical status IV
- Age \< 18 years or \> 65 years
- BMI \< 20 kg/m² or \> 35 kg/m²
- Known allergy or contraindication to local anesthetics or opioids used in the study
- History of chronic pain or psychological disorders
- Contraindications to regional anesthesia (e.g., local infection, coagulopathy, pre-existing peripheral neuropathy)
- Severe respiratory, cardiac, hepatic, or renal disease
Where it is running
1 location listed.
- National Cancer Institute - Cairo University - Cairo, Egypt